ABIVAX Société Anonyme (ABVX:NASDAQ) closed at $92.38 on October 15, 2026, up 5.00% on the day. The stock trades 37.9% below its 52-week high of $148.83 and 32.3% above its 52-week low of $69.81. Over the past year, it lost 0.6%. ABIVAX Société Anonyme is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +6.26% | -9.64% | -29.75% | -19.66% | -0.57% |
In 252 trading sessions since October 15, 2025, ABVX closed higher on 116 days (46%). Its best day was June 30, 2026 (+38.60%) and its worst was June 2, 2026 (-44.10%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 4 times.
Abivax is focused on developing innovative treatments that harness the body¿s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Find more stocks like ABVX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.